TABLE 3.
Strain | Origina | Isolation dateb | PCR ribotype | Compound RAPD codec | Conventional ribotype | PFGE type |
---|---|---|---|---|---|---|
Epidemiologically unrelated international isolates | ||||||
1 | U.K. | 1993 | A | A/A | A | A |
2 | U.K. | 1993 | A | A/A | B | B |
3 | U.S. | 1988 | A | A/A | C | C |
4 | France | 1989 | A | A/A | D | D |
5 | France | 1989 | A | A/A | E | E |
6 | New Zealand | 1989 | A | A/A | C | C |
7 | France | 1989 | A | A/A | F | F |
8 | France | 1988 | A | A/A | B | B |
9 | France | 1986 | A | A/A | A | A |
10 | France | 1984 | A | A/A | E | B |
Strains from patients involved in outbreak | ||||||
12 | Pat. 5 | 8-96 | A | A/A | E | B |
13 | Pat. 3 | 11-95 | A | A/A | G | B |
14 | Pat. 2 | 10-95 | A | A/A | E | B |
15 | Pat. 1 | 10-95 | A | A/A | C | C |
16 | Pat. 4 | 8-96 | A | A/A | E | B |
17 | Pat. 6 | 9-96 | A | A/A | E | B |
Strains from surgeon A | ||||||
11 | Nose | 10-96 | A | A/A | C | G |
19 | Shedding | 10-96 | A | A/A | C | G |
20 | Nose | 10-96 | A | A/A | C | H |
21 | Shedding | 10-96 | A | A/A | C | H |
22 | Shedding | 10-96 | A | A/A | C | G |
23 | Shedding | 10-96 | A | A/A | C | H |
24 | Nose | 10-96 | A | A/A | C | H |
25 | Shedding | 10-96 | A | A/A | C | H |
Strains not involved in outbreak | ||||||
18 | 95-1-2cd | 1995 | A | A/A | A | C |
26 | Pat. nose | 1997 | B | B/B | E | I |
U.K., United Kingdom; U.S., United States; Pat., patient.
Dates for strains isolated from patients involved in the outbreak and from surgeon A are given as month-year.
The first letter in the compound RAPD code identifies the ERIC1-ERIC2 result; the second letter identifies the RAPD1-RAPD7 score.
Strain from a quality control study conducted by the Dutch Foundation for Quality Assessment of Medical Microbiological Laboratories (SKMM).